Author: Ivan Oransky

Former Florida ob-gyn prof notches eighth retraction

University of Florida
University of Florida

Nasser Chegini, the former University of Florida professor currently under investigation by the Office of Research Integrity (ORI), has now had eight papers retracted.

The eighth paper, in the journal Reproductive Biology and Endocrinology, is about the effect of a compound used during fertility treatments on Smads, signaling molecules that carry messages from TGF-beta receptors to the nucleus. It’s being retracted disappeared due to the discovery of data that “have been fabricated or falsified by the last author” — namely, Chegini.

Here’s more from the notice for “Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells:” Continue reading Former Florida ob-gyn prof notches eighth retraction

Retraction Watch is hiring!

anniversarySince becoming our intern in June of last year, and then our first-ever staff writer in October, Cat Ferguson has written more than 200 posts, breaking news left and right. But as we noted on Twitter the other day with not a small degree of sadness, Cat has left Retraction Watch for a great gig at BuzzFeed.

That means we’re hiring.

The job is definitely fast-paced. Continue reading Retraction Watch is hiring!

Weekend reads: Faith-based peer review; lab bloopers; post-publication peer review etiquette

The week at Retraction Watch featured a lawsuit over the authorship of a paper, and a look at when exactly a study should be retracted. Here’s what was happening elsewhere:

Continue reading Weekend reads: Faith-based peer review; lab bloopers; post-publication peer review etiquette

When should a paper be retracted? A tale from the obesity literature

obesity factsIn our line of work, we see it all — mega-corrections that don’t quite rise to the level of retraction, letters to the editor that point out seemingly fatal flaws in papers that remain untouched, and studies retracted for what seem like minor reasons. It can make you wonder what makes a paper worthy of a retraction. A recent case in an obesity journal may not provide a definitive answer, but it gives us a lot to chew on.

Here’s the story: In September 2013, Rosely Sichieri and a colleague from the State University of Rio de Janeiro submitted an article to Obesity Facts, “Unbalanced Baseline in School-Based Interventions to Prevent Obesity: Adjustment Can Lead to Bias?” The article examined statistical issues in randomized controlled trials of school-based weight loss programs. Peer reviewers said the paper needed major revisions before it could be accepted; the authors revised the paper enough in a second draft, submitted in November 2013, that the original reviewers accepted it. The paper was published in June 2014.

Then, in September 2014, a group of authors including David Allison of the University of Alabama, Birmingham, and colleagues from Clemson, Thomas Jefferson, and the University of Minnesota, wrote a critical letter that was published in the journal in April. The letter, according to a just-published editorial: Continue reading When should a paper be retracted? A tale from the obesity literature

Urology researcher in Iran up to six retractions

safarinejadA urologist in Iran has lost three papers in BJU International, bringing his retraction count to a half-dozen.

In December 2013, we reported on three retractions by Mohammad Reza Safarinejad. None of those notices, about papers related to incontinence and erectile dysfunction, made the reasons for retraction very clear. After that post ran, Safarinejad told us that Hartmut Porst, former president of the European Society for Sexual Medicine, had raised questions about the data in a number of his papers. Porst confirmed that for us earlier this month.

All of the latest papers, about aspects of male sexual dysfunction, are being retracted due to “inappropriate” statistical analyses.

Here’s the notice for “Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation,” which has been cited 17 times, according to Thomson Scientific’s Web of Knowledge: Continue reading Urology researcher in Iran up to six retractions

Author from China blames translation company for plagiarism in retracted vascular paper

apjcpDo we need a “throwing vendors under the bus” category here at Retraction Watch?

Earlier this year, we reported on the retraction of a paper because of sloppy work by an outside lab. Now, we have the story of a retraction for “negligence” by a translator. Specifically, the author says the passages shared between the retracted 2015 vascular paper and another paper in EMBO Journal are a result of “negligence on the part of the translation company that I trusted to make my manuscript ready for submission.”

Here’s more from the notice in the Asian Pacific Journal of Cancer Prevention, written by Yong Jiang, of Laboratory Medical College, Jilin Medical College, China: Continue reading Author from China blames translation company for plagiarism in retracted vascular paper

Bielawski and Wiggins retraction count grows to six

chemical scienceA group of chemists whose work was investigated by the University of Texas-Austin has had another paper retracted, this one of a Chemical Science study previously subjected to an Expression of Concern.

That makes six retractions for Christopher Bielawski and Kelly Wiggins.

Here’s the notice for “Homonuclear bond activation using a stable N,N′-diamidocarbene”, signed by all three authors of the paper: Continue reading Bielawski and Wiggins retraction count grows to six

Weekend reads: Aussie scientists bend rules; how to fix peer review once and for all; crazy structure alert

booksThe week at Retraction Watch featured the retraction of 11 papers by a controversial researcher in Italy, and a look at the controversy over lead in the water supply. Here’s what was happening elsewhere: Continue reading Weekend reads: Aussie scientists bend rules; how to fix peer review once and for all; crazy structure alert

Nature retracts epigenetics paper by author who lost two Science papers last year

cover_natureFrank Sauer, formerly of the University of California, Riverside, has had a 2002 letter on epigenetics retracted from Nature due to “inappropriate image manipulation.”

Sauer had two papers retracted from Science last year following a university investigation. Here’s the Nature notice for “Histone methylation by the Drosophila epigenetic transcriptional regulator Ash1:” Continue reading Nature retracts epigenetics paper by author who lost two Science papers last year

Investigations into Voinnet’s work announced; critic publishes original peer review

Olivier Voinnet
Olivier Voinnet

The story about Olivier Voinnet, a high-profile plant biologist whose work has fallen under scrutiny, continues to build momentum. Late last week, Voinnet’s employer and one of his funders announced they were investigating his work, and one of the peer reviewers of a soon-to-be-retracted paper has made her original report public.

Here’s the statement from CNRS, which funds Voinnet: Continue reading Investigations into Voinnet’s work announced; critic publishes original peer review